NCT07416253 2026-02-18Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast CancerHenan Cancer HospitalPhase 2 Not yet recruiting68 enrolled